83 related articles for article (PubMed ID: 15958622)
1. Low-molecular weight caldesmon as a potential serum marker for glioma.
Zheng PP; Hop WC; Sillevis Smitt PA; van den Bent MJ; Avezaat CJ; Luider TM; Kros JM
Clin Cancer Res; 2005 Jun; 11(12):4388-92. PubMed ID: 15958622
[TBL] [Abstract][Full Text] [Related]
2. High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.
Iwadate Y; Hayama M; Adachi A; Matsutani T; Nagai Y; Hiwasa T; Saeki N
Anticancer Res; 2008; 28(1B):415-8. PubMed ID: 18383878
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
[TBL] [Abstract][Full Text] [Related]
4. Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ.
Ludwig N; Keller A; Comtesse N; Rheinheimer S; Pallasch C; Fischer U; Fassbender K; Steudel WI; Lenhof HP; Meese E
Clin Cancer Res; 2008 Aug; 14(15):4767-74. PubMed ID: 18676746
[TBL] [Abstract][Full Text] [Related]
5. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
6. [S100 protein in tumours of the central nervous system].
Ortiz-Muñoz B; Menéndez-López A; Yayá-Tur R; Arribas-Alpuente L; Maiquez-Richart J; Bordes-Monmeneu M
Rev Neurol; 2003 Jun 1-15; 36(11):1011-5. PubMed ID: 12808493
[TBL] [Abstract][Full Text] [Related]
7. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid and serum carcinoembryonic antigen in brain tumors.
Batabyal SK; Ghosh B; Sengupta S; Ghosh SN; Chatterjee R
Neoplasma; 2003; 50(5):377-9. PubMed ID: 14628092
[TBL] [Abstract][Full Text] [Related]
9. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
10. p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas.
Wakabayashi T; Natsume A; Hatano H; Fujii M; Shimato S; Ito M; Ohno M; Ito S; Ogura M; Yoshida J
Neurosurgery; 2009 Mar; 64(3):455-61; discussion 461-2. PubMed ID: 19240607
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.
Lee HY; Na DG; Song IC; Lee DH; Seo HS; Kim JH; Chang KH
J Comput Assist Tomogr; 2008; 32(2):298-303. PubMed ID: 18379322
[TBL] [Abstract][Full Text] [Related]
12. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
14. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
15. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
[TBL] [Abstract][Full Text] [Related]
16. CA 125: a potential tumor marker for gallbladder cancer.
Chaube A; Tewari M; Singh U; Shukla HS
J Surg Oncol; 2006 Jun; 93(8):665-9. PubMed ID: 16724349
[TBL] [Abstract][Full Text] [Related]
17. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
[TBL] [Abstract][Full Text] [Related]
18. Highly sensitive detection of melanoma at an early stage based on the increased serum secreted protein acidic and rich in cysteine and glypican-3 levels.
Ikuta Y; Nakatsura T; Kageshita T; Fukushima S; Ito S; Wakamatsu K; Baba H; Nishimura Y
Clin Cancer Res; 2005 Nov; 11(22):8079-88. PubMed ID: 16299239
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
